Collagen Q is a key player for developing rational therapy for congenital myasthenia and for dissecting the mechanisms of anti-MuSK myasthenia gravis

Journal of Molecular Neuroscience

Volumn 53, Issue 3, 2014, Pages 359-361

  Ohno, Kinji ^a   Ito, Mikako ^a   Kawakami, Yu ^a   Ohtsuka, Kenji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholinesterase; Collagen Q; Congenital myasthenic syndrome; MuSK; Myasthenia gravis

Indexed keywords

ACETYLCHOLINESTERASE; COLLAGEN; COLLAGEN Q; IMMUNOGLOBULIN G; MUSK ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; CHOLINERGIC RECEPTOR; MUSK PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ADENO ASSOCIATED VIRUS; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONGENITAL MYASTHENIC SYNDROME; HUMAN; MOTOR PERFORMANCE; MUTATION; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NONHUMAN; SEROTYPE; SYNAPTIC TRANSMISSION; ULTRASTRUCTURE; ANIMAL; DRUG EFFECTS; EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS; GENETICS; IMMUNOLOGY; METABOLISM; MYASTHENIC SYNDROMES, CONGENITAL; NERVE ENDING;

ADENO-ASSOCIATED VIRUS; MUS;

ACETYLCHOLINESTERASE; ANIMALS; ANTIBODIES; COLLAGEN; HUMANS; MOTOR ENDPLATE; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; MYASTHENIC SYNDROMES, CONGENITAL; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 84905008931     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0170-x     Document Type: Article

References (15)

1. Cartaud A, Strochlic L, Guerra M et al (2004) MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J Cell Biol 165:505-515 (Pubitemid 38679616)
2. Deprez P, Inestrosa NC, Krejci E (2003) Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesterase. J Biol Chem 278:23233-23242 (Pubitemid 36830136)
3. Farrugia ME, Vincent A (2010) Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol 23:489-495
4. Farrugia ME, Robson MD, Clover L et al (2006) MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 129:1481-1492 (Pubitemid 43999381)
5. Higuchi O, Hamuro J, Motomura M, Yamanashi Y (2011) Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69:418-422
6. Ito M, Suzuki Y, Okada T et al (2012) Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction. Mol Ther 20:1384-1392
7. Kawakami Y, Ito M, Hirayama M et al (2011) Anti-MuSK auto-antibodies block binding of collagen Q to MuSK. Neurology 77:1819-1826
8. Kim N, Stiegler AL, Cameron TO et al (2008) Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135:334-342
9. Kimbell LM, Ohno K, Engel AG, Rotundo RL (2004) C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J Biol Chem 279:10997-11005 (Pubitemid 38401591)
10. McConville J, Farrugia ME, Beeson D et al (2004) Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 55:580-584 (Pubitemid 38391977)
11. Mihaylova V, Muller JS, Vilchez JJ et al (2008) Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain 131:747-759 (Pubitemid 351294715)
12. Ohno K, Brengman J, Tsujino A, Engel AG (1998) Human endplate acetylcholinesterase deficiency caused by mutations in the collagenlike tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A 95:9654-9659 (Pubitemid 28506287)
13. Pasnoor M, Wolfe GI, Nations S et al (2010) Clinical findings in MuSKantibody positive myasthenia gravis: a U.S. experience. Muscle Nerve 41:370-374
14. Sigoillot SM, Bourgeois F, Lambergeon M, Strochlic L, Legay C (2010) ColQ controls postsynaptic differentiation at the neuromuscular junction. J Neurosci 30:13-23
15. Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC, Mei L (2008) LRP4 serves as a coreceptor of agrin. Neuron 60:285-297